JEAN JACQUES BIENAIME - 01 Jun 2024 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
01 Jun 2024
Net transactions value
$0
Form type
3
Filing time
05 Jun 2024, 16:10:36 UTC
Previous filing
22 May 2024
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KROS Common Stock 200 01 Jun 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.